SCHEMBL4915757

SCHEMBL4915757

CCOC(=O)c1[c]nccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
CDC7 O00311 6/20 0.40
DBF4 Q9UBU7 6/20 0.40
TSHR P16473 1/20 0.40
KDM4E B2RXH2 4/20 0.38
CA12 O43570 3/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA7 P43166 3/20 0.38
CA9 Q16790 3/20 0.38
CA14 Q9ULX7 3/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
BRD4 O60885 1/20 0.38
NUDT1 P36639 1/20 0.38
ALOX15 P16050 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TRPM8 Q7Z2W7 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8860798 0.86 ALDH1A1 (0.43) TSHRKDM4EESR1L3MBTL1ALDH1A1
SCHEMBL130016 0.74 CYP1A2 (0.43) CYP1A2TSHRKDM4ECA12CA1
SCHEMBL6197063 0.74 CYP1A2 (0.43) CYP1A2CDC7DBF4TSHRKDM4E
SCHEMBL21843252 0.72 BRD4 (0.56) CYP1A2TSHRKDM4ECA12CA1
SCHEMBL5307910 0.70 CYP1A2 (0.40) CYP1A2TSHRKDM4ECA12CA1
SCHEMBL2875121 0.70 CYP1A2 (0.47) CYP1A2CDC7DBF4TSHRKDM4E
SCHEMBL26081236 0.68 BRD4 (0.51) CYP1A2TSHRKDM4EBRD4ALOX15
SCHEMBL750492 0.68 BRD4 (0.51) CYP1A2TSHRKDM4ECA12CA1
SCHEMBL5309848 0.68 KDM4E (0.45) CYP1A2CDC7DBF4TSHRKDM4E
SCHEMBL4921787 0.68 CYP1A2 (0.41) CYP1A2TSHRKDM4ECA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200475-A1 4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors PFIZER INC. 2008-08-21 US disclosed
EP-1866317-A1 4-PIPERAZINOTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS Pharmacia & Upjohn Company LLC (US) 2007-12-19 EP disclosed
WO-2006103555-A1 4-PIPERAZINOTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200475-A1 4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors PF4, TBXA2R, P2RY4 CYP1A2 578/4885CDC7 3222/4885DBF4 2364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.